Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ligand-independent EPHA2 signaling sustains neural progenitors via ECSIT and NAD<sup></sup>.

EMBO reports·2026
Same author

Ambient Light-Activatable Luminescent Particle-Embedded Conformal Patch for Photochemical Tissue Bonding and Photobiomodulated Healing.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Induced alanine auxotrophy as a therapeutic strategy against <i>Mycobacterium tuberculosis</i>.

bioRxiv : the preprint server for biology·2026
Same author

Ion-coupled transfersome complexes for enhanced transdermal NAD<sup>+</sup> repletion and mitigation of cellular senescence signatures.

Materials today. Bio·2026
Same author

Chitosan-shielded stem cell exosomes as a tight-junction-modulating bio-shuttle for enhanced transdermal delivery and skin rejuvenation.

International journal of biological macromolecules·2026
Same author

Ca<sup>2+</sup>/calmodulin-dependent inhibitors of adenylyl cyclase 1 as novel nonopioid analgesics for chronic inflammatory pain.

Molecular pharmacology·2026

Related Experiment Video

Updated: Sep 23, 2025

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

4.6K

Supramolecular hydrogels encapsulating bioengineered mesenchymal stem cells for ischemic therapy.

Byung Woo Hwang1, Young-Eun Kim2, Mungu Kim3

  • 1Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH) 77 Cheongam-ro Pohang 37673 Korea.

RSC Advances
|May 11, 2022
PubMed
Summary

Supramolecular hyaluronate hydrogels successfully encapsulated genetically engineered mesenchymal stem cells (MSCs). These engineered cells stably produced angiogenic factors, leading to effective vascular repair and improved blood flow in limb ischemia treatment.

More Related Videos

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
06:15

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.

Published on: June 14, 2015

8.8K
Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
09:37

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering

Published on: October 26, 2009

37.1K

Related Experiment Videos

Last Updated: Sep 23, 2025

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

4.6K
A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
06:15

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.

Published on: June 14, 2015

8.8K
Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
09:37

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering

Published on: October 26, 2009

37.1K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Stem Cell Therapy

Background:

  • Limb ischemia requires effective vascular repair strategies.
  • Mesenchymal stem cells (MSCs) show therapeutic potential but require suitable delivery systems.
  • Hyaluronate (HA) hydrogels offer biocompatible matrices for cell encapsulation.

Purpose of the Study:

  • To develop supramolecular hyaluronate hydrogels for encapsulating genetically engineered MSCs (BMSCs).
  • To evaluate the efficacy of BMSCs within these hydrogels for treating limb ischemia.
  • To assess the angiogenic factor production and vascular repair capabilities.

Main Methods:

  • Development of supramolecular hyaluronate hydrogels.
  • Genetic engineering of MSCs to produce angiogenic factors (BMSCs).
  • Encapsulation of BMSCs within HA hydrogels.
  • In vivo evaluation of hydrogel-cell constructs for limb ischemia treatment.

Main Results:

  • Stable encapsulation of BMSCs within supramolecular HA hydrogels was achieved.
  • Bioengineered MSCs (BMSCs) demonstrated stable production of angiogenic factors in vivo.
  • Effective vascular repair and enhanced blood perfusion were observed in treated limbs.

Conclusions:

  • Supramolecular HA hydrogels provide a viable platform for delivering engineered MSCs.
  • This approach shows significant potential for treating limb ischemia through stable angiogenic factor delivery and vascular regeneration.